Provided by Tiger Trade Technology Pte. Ltd.

Novo-Nordisk A/S

45.33
-0.2800-0.61%
Pre-market: 45.400.0700+0.15%07:27 EDT
Volume:7.61M
Turnover:344.95M
Market Cap:200.50B
PE:11.32
High:45.61
Open:45.28
Low:44.95
Close:45.61
52wk High:64.16
52wk Low:35.12
Shares:4.42B
Float Shares:3.19B
Volume Ratio:0.68
T/O Rate:0.24%
Dividend:1.72
Dividend Rate:3.80%
EPS(TTM):4.00
EPS(LYR):3.62
ROE:59.82%
ROA:18.73%
PB:6.16
PE(LYR):12.52

Loading ...

Veru Enters Supply Agreement With Novo Nordisk for Obesity Study; Shares Surge

MT Newswires Live
·
Jun 05

Veru pact with Novo ‘significant event,’ says Canaccord

TIPRANKS
·
Jun 05

Veru announces clinical supply agreement with Novo Nordisk

TIPRANKS
·
Jun 05

Novo Nordisk Expands Obesity Pipeline With New First‑in‑Human Trial for NNC0113-5840

TIPRANKS
·
Jun 05

Movement Alert|Novo Nordisk Rises 3.12% in Regular Trading, Pharmaceutical Sector Rallies as Oral Wegovy Expands Internationally

Market Focus
·
Jun 04

Novo Nordisk (0QIU) Gets a Hold from Goldman Sachs

TIPRANKS
·
Jun 04

Novo Nordisk A/S Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Jun 04

Dow Jones Top Company Headlines at 7 AM ET: Baidu Sees AI, Chip Business Driving Healthy Revenue Growth | Zara ...

Dow Jones
·
Jun 03

Novo Nordisk's UAE Wegovy Pill Launch an Important Step -- Market Talk

Dow Jones
·
Jun 03

Novo Nordisk Launches Wegovy Oral Weight-Loss Drug in UAE, Its First Market Outside the United States

Deep News
·
Jun 03

EXCLUSIVE-Cigna drops coverage of GLP-1 obesity drugs for its own employees

Reuters
·
Jun 03

Movement Alert|Novo Nordisk Falls 3.17% in Regular Trading, Pharma Sector Weakness Compounded by Worsening Obesity Drug Competition

Market Focus
·
Jun 02

Novo Nordisk Partners With Metabolic for Early Access to Oral Wegovy in UAE

MT Newswires Live
·
Jun 02

Novo Nordisk A/S Stock Falls Monday, Underperforms Market

Dow Jones
·
Jun 02

Moderately bullish activity in Novo Nordisk with shares down 2.99%

TIPRANKS
·
Jun 01

Movement Alert|Novo Nordisk Falls 3.09% in Regular Trading, Pharma Sector Broadly Weak Amid Intensifying GLP-1 Competition

Market Focus
·
Jun 01

Assessing Novo Nordisk (NYSE:NVO) Valuation After Mixed Returns And Earnings Snapshot

Simply Wall St.
·
May 30

Cboe data suggests bullish flow in Novo Nordisk with shareslittle changed

TIPRANKS
·
May 30

Novo Nordisk’s CagriSema Trial Puts Next-Generation Obesity Strategy in Focus

TIPRANKS
·
May 30

Novo Nordisk A/S Stock Falls Friday, Underperforms Market

Dow Jones
·
May 30